BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7402 related articles for article (PubMed ID: 12692171)

  • 1. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical and scientific considerations for chemoprevention research in cohorts at genetic risk for breast cancer.
    Nayfield SG
    J Cell Biochem Suppl; 1996; 25():123-30. PubMed ID: 9027608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive health and blurred professional boundaries.
    Chavkin W; Breitbart V
    Womens Health Issues; 1996; 6(2):89-96. PubMed ID: 8932462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition testing: clinical implications for oncology nurses.
    Calzone KA
    Oncol Nurs Forum; 1997 May; 24(4):712-8. PubMed ID: 9159785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notification of a family history of breast cancer: issues of privacy and confidentiality.
    Winter PR; Wiesner GL; Finnegan J; Bartels D; LeRoy B; Chen PL; Sellers TA
    Am J Med Genet; 1996 Dec; 66(1):1-6. PubMed ID: 8957501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethical legal and social issues in pre-symptomatic testing for cancer susceptibility in familial tumors].
    Tsunematsu Y
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):945-50. PubMed ID: 9212802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Telecommunications, health and radiology: potential synergies for the new millennium].
    Lagalla R
    Radiol Med; 2001; 102(1-2):14-9. PubMed ID: 11677432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a cancer risk evaluation program.
    Calzone KA; Stopfer J; Blackwood A; Weber BL
    Cancer Pract; 1997; 5(4):228-33. PubMed ID: 9250079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic testing for cancer susceptibility: the present situation in Japan].
    Miki Y
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):930-7. PubMed ID: 9212800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women.
    Howard J; Beckwith L
    NIDA Res Monogr; 1996; 166():68-86. PubMed ID: 8818166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues.
    Patenaude AF
    Behav Sci Law; 1996; 14(4):393-410. PubMed ID: 9156420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations.
    Wilfond BS; Fost N
    Milbank Q; 1992; 70(4):629-59. PubMed ID: 1435628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evaluation of cancer: the importance of family history.
    Chew HK
    Tex Med; 2001 Feb; 97(2):40-5. PubMed ID: 11233057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizing cancer genetics programs: the Swiss model.
    Pichert G; Stahel RA
    J Clin Oncol; 2000 Nov; 18(21 Suppl):65S-9S. PubMed ID: 11060330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis.
    Applebaum-Shapiro SE; Peters JA; O'Connell JA; Aston CE; Whitcomb DC
    Am J Gastroenterol; 2001 May; 96(5):1610-7. PubMed ID: 11374708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioethics for clinicians: 14. Ethics and genetics in medicine.
    Burgess MM; Laberge CM; Knoppers BM
    CMAJ; 1998 May; 158(10):1309-13. PubMed ID: 9614824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to control cancer through genetics.
    Berg K
    Princess Takamatsu Symp; 1987; 18():283-94. PubMed ID: 3333497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic discrimination in health insurance: an overview and analysis of the issues.
    Roth MT; Painter RB
    Nurs Clin North Am; 2000 Sep; 35(3):731-56. PubMed ID: 10957687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 371.